DVA — DAVITA INC.
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 927066 ·
Last close
$198.19
Market Cap
$12.72B
52W High
$202.69
52W Low
$143.07
ADV30
964,260
Next earnings
2026-08-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 3,415,548,000 | 1,073,291,000 | 473,548,000 | 197,530,000 | 17,499,365,000 | 644,243,000 | 16,451,199,000 |
| Dec 2025 | 3,619,787,000 | 1,210,270,000 | 551,205,000 | 234,217,000 | 17,480,103,000 | 676,438,000 | 16,321,665,000 |
| Sep 2025 | 3,420,227,000 | 1,087,468,000 | 495,605,000 | 150,332,000 | 17,555,892,000 | 705,960,000 | 16,215,170,000 |
| Jun 2025 | 3,379,526,000 | 1,117,986,000 | 530,477,000 | 199,337,000 | 17,492,958,000 | 708,417,000 | 15,939,935,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,027,322,000
Investing CF
$-631,902,000
Financing CF
$-1,205,583,000
CapEx
$-534,624,000
Dividends Paid
—
Buybacks
$-1,647,465,000
EPS Diluted TTM
$10.78
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-179,242,000
Inventory
$141,613,000
Receivables
$3,012,788,000
ST Investments
$22,303,000
EBIT TTM
$1,991,726,000
Pretax Income TTM
$1,401,724,000
Interest Exp TTM
$590,002,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$13,835,087,872
EBITDA
$2,792,761,088
Free Cash Flow
$999,662,976
Enterprise Value
$26,689,492,992
Total Cash
$666,545,984
Total Debt
$13,220,841,472
Shares Out
64,185,000
Trailing EPS
$10.37
Book Value
$-11.41
ROE
81.0%
ROA
7.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,643,069,000 | 2,010,615,000 | 746,803,000 | 17,480,103,000 | 16,321,665,000 | — | 1,886,500,000 |
| Dec 2024 | 12,815,550,000 | 1,954,828,000 | 936,342,000 | 17,285,268,000 | 15,193,917,000 | — | 2,022,038,000 |
| Dec 2023 | 12,140,147,000 | 1,601,003,000 | 691,535,000 | 16,893,578,000 | 14,150,228,000 | — | 2,059,031,000 |
| Dec 2022 | 11,609,894,000 | 1,312,542,000 | 560,400,000 | 16,928,252,000 | 14,703,452,000 | — | 1,564,570,000 |
TTM Snapshot
Revenues TTM
$12,271,935,000
NetIncome TTM
$826,440,000
OpCashFlow TTM
$0
Assets (Latest)
$17,285,268,000
Forward EPS
$17.18
Max Pain — expiry 2026-12-18
max pain strike: $120.00 · spot: $198.19 · call oi: 221 · put oi: 5,984
Expected Move to 2026-12-18:
±$49.85
(25.15%) —
implied range
$148.34 –
$248.04
· ATM straddle on $200.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FMCQF | Fresenius Medical Care AG | $12.13B | $45.17 | — |
| FMS | Fresenius Medical Care AG | $12.00B | $22.35 | — |
| BTSG | BrightSpring Health Services, Inc. | $11.97B | $61.00 | — |
| THC | TENET HEALTHCARE CORP | $14.33B | $166.36 | — |
| EHC | Encompass Health Corp | $10.34B | $104.19 | — |
News headlines (Yahoo Finance, 1h cache)
4 Outpatient Home Health Stocks Benefiting From Industry Trends
2026-06-09 14:40 · Yahoo
Best Growth Stocks to Buy for June 9th
2026-06-09 10:22 · Yahoo
Best Value Stocks to Buy for June 9th
2026-06-09 09:14 · Yahoo
FMS and Home Dialysis: How 5008X Could Reset Demand
2026-06-08 18:51 · Yahoo
Assessing DaVita (DVA) Valuation After Strong Q1 2026 Beat And Upgraded Guidance
2026-06-06 11:10 · Yahoo
Q1 Earnings Highs And Lows: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks
2026-06-05 08:40 · Yahoo
Akebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Near
2026-06-05 00:05 · Yahoo
DaVita Expands Comprehensive Kidney Care Through Dialysis Services
2026-06-04 17:41 · Yahoo
DaVita HealthCare (DVA) Up 0.6% Since Last Earnings Report: Can It Continue?
2026-06-04 15:30 · Yahoo
Best Growth Stocks to Buy for June 4th
2026-06-04 09:34 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.